Literature DB >> 26174602

Aurora kinase A is essential for correct chromosome segregation in mouse zygote.

Veronika Kovarikova1, Jan Burkus1, Pavol Rehak1, Adela Brzakova2, Petr Solc2, Vladimir Baran3.   

Abstract

Aurora-A kinase (AURKA), a member of the serine/threonine protein kinase family, is involved in multiple steps of mitotic progression. It regulates centrosome maturation, mitotic spindle formation, and cytokinesis. While studied extensively in somatic cells, little information is known about AURKA in the early cleavage mouse embryo with respect to acentrosomal spindle assembly. In vitro experiments in which AURKA was inactivated with specific inhibitor MLN8237 during the early stages of embryogenesis documented gradual arrest in the cleavage ability of the mouse embryo. In the AURKA-inhibited 1-cell embryos, spindle formation and anaphase onset were delayed and chromosome segregation was defective. AURKA inhibition increased apoptosis during early embryonic development. In conclusion these data suggest that AURKA is essential for the correct chromosome segregation in the first mitosis as a prerequisite for normal later development after first cleavage.

Entities:  

Keywords:  Apoptosis; Aurora A; MLN8237; Mouse zygote; Spindle

Mesh:

Substances:

Year:  2015        PMID: 26174602     DOI: 10.1017/S0967199415000222

Source DB:  PubMed          Journal:  Zygote        ISSN: 0967-1994            Impact factor:   1.442


  4 in total

1.  Aurora kinase genetic polymorphisms: an association study in Down syndrome and spontaneous abortion.

Authors:  Carolina Monteiro Leite de Castro; Carolina Oliveto Bastos Pereira; Joissy Aprigio; Marcelo A Costa Lima; Márcia G Ribeiro; Márcia Rodrigues Amorim
Journal:  Hum Cell       Date:  2022-02-26       Impact factor: 4.374

2.  RNA interference in head and neck oncology.

Authors:  Agnieszka Sobecka; Wojciech Barczak; Wiktoria Maria Suchorska
Journal:  Oncol Lett       Date:  2016-09-02       Impact factor: 2.967

Review 3.  Aurora kinases: novel therapy targets in cancers.

Authors:  Anqun Tang; Keyu Gao; Laili Chu; Rui Zhang; Jing Yang; Junnian Zheng
Journal:  Oncotarget       Date:  2017-04-04

4.  Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy.

Authors:  Yuqian Liao; Yulu Liao; Jun Li; Junyu Li; Ying Fan; Binghe Xu
Journal:  Cancer Manag Res       Date:  2018-09-21       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.